Clinical Trial Update: Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the combination of carboplatin and temozolomide in patients with unresectable or metastatic melanoma. The current status of the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Mount Vernon Cancer Centre at Mount Vernon Hospital | Conditions: Melanoma (Skin) | Phase 1 | Status: UNKNOWN